RecruitingPhase 2Phase 3NCT04971577

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Efficacy of Simvastatin in Reducing Liver Fibrosis in Patients With Advanced Fibrosis Due to Alcohol: Randomized, Double-blind, Placebo-controlled Clinical Trial

Sponsor

Anna Cruceta

Enrollment

90 participants

Start Date

Feb 22, 2022

Study Type

INTERVENTIONAL

Conditions

Liver Fibrosis Alcohol Abuse

Summary

Evaluate the efficacy of simvastatin in reducing liver fibrosis in patients with advanced fibrosis due to alcohol

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Simvastatin 40mg for people with alcohol abuse and liver fibrosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.